Page last updated: 2024-08-25

chitosan and Psoriasis

chitosan has been researched along with Psoriasis in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (27.27)24.3611
2020's8 (72.73)2.80

Authors

AuthorsStudies
Abdel-Mottaleb, MMA; Arafa, MG; El-Zaafarany, GM; Fereig, SA2
Fu, S; Lai, R; Liu, Z; Lu, Y; Luo, W; Wang, Y; Xu, Y1
Abdel-Mottaleb, MMA; Arafa, MG; El-Zaafarany, GM; Fereig, S1
Al-Nemrawi, NK; Alzoubi, KH; Khafajah, AS1
Abourehab, MAS; Hazari, SA; Kesharwani, P; Sheikh, A; Tulbah, AS1
Pu, S; Sun, L; Zhao, K; Zhou, D1
Alshehri, SA; Hazari, SA; Kesharwani, P; Molugulu, N; Sahebkar, A; Sheikh, A; Wahab, S1
Adame, S; Adhami, VM; Babatunde, AS; Bharali, DJ; Chamcheu, JC; Esnault, S; Longley, BJ; Massey, RJ; Mousa, SA; Mukhtar, H; Siddiqui, IA; Wood, GS1
Gomez, C; Muangnoi, C; Rojsitthisak, P; Sorasitthiyanukarn, FN; Wongpiyabovorn, J1
Bonferoni, MC; Catanzaro, M; Faccendini, A; Ferrari, F; Lanni, C; Malavasi, L; Malgarim Cordenonsi, L; Platcheck Raffin, R; Rossi, S; Sandri, G; Scherman Schapoval, EE1

Other Studies

11 other study(ies) available for chitosan and Psoriasis

ArticleYear
Self-assembled tacrolimus-loaded lecithin-chitosan hybrid nanoparticles for in vivo management of psoriasis.
    International journal of pharmaceutics, 2021, Oct-25, Volume: 608

    Topics: Animals; Chitosan; Drug Carriers; Lecithins; Mice; Nanoparticles; Particle Size; Psoriasis; Tacrolimus

2021
Chitosan/hyaluronan nanogels co-delivering methotrexate and 5-aminolevulinic acid: A combined chemo-photodynamic therapy for psoriasis.
    Carbohydrate polymers, 2022, Feb-01, Volume: 277

    Topics: Aminolevulinic Acid; Cell Line; Chitosan; Drug Therapy, Combination; Humans; Hyaluronic Acid; Levulinic Acids; Lipopolysaccharides; Methotrexate; Nanogels; Photosensitizing Agents; Psoriasis

2022
Boosting the anti-inflammatory effect of self-assembled hybrid lecithin-chitosan nanoparticles via hybridization with gold nanoparticles for the treatment of psoriasis: elemental mapping and
    Drug delivery, 2022, Volume: 29, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Chitosan; Gold; Lecithins; Metal Nanoparticles; Mice; Psoriasis; Tacrolimus

2022
Novel Chitosan Nanoparticles Loaded with Methotrexate for Topical Treatment of Psoriasis.
    Pharmaceutical nanotechnology, 2023, Volume: 11, Issue:5

    Topics: Animals; Chitosan; Methotrexate; Mice; Nanoparticles; Psoriasis; Rats; Skin

2023
Self-assembled Gallic acid loaded lecithin-chitosan hybrid nanostructured gel as a potential tool against imiquimod-induced psoriasis.
    Environmental research, 2023, 10-01, Volume: 234

    Topics: Chitosan; Gallic Acid; Humans; Imiquimod; Lecithins; Nanoparticles; Particle Size; Psoriasis

2023
Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice.
    International journal of nanomedicine, 2023, Volume: 18

    Topics: Animals; Cell Proliferation; Chitosan; Dermatitis; Disease Models, Animal; Imiquimod; Inflammation; Interleukin-17; Interleukin-6; Keratinocytes; Mice; Mice, Inbred BALB C; Nanoparticles; Psoriasis; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2023
Hyaluronic acid engineered gallic acid embedded chitosan nanoparticle as an effective delivery system for treatment of psoriasis.
    Environmental research, 2023, 12-01, Volume: 238, Issue:Pt 1

    Topics: Chitosan; Gallic Acid; Humans; Hyaluronic Acid; Nanoparticles; Psoriasis

2023
Tacrolimus-loaded chitosan nanoparticles for enhanced skin deposition and management of plaque psoriasis.
    Carbohydrate polymers, 2021, Sep-15, Volume: 268

    Topics: Administration, Cutaneous; Animals; Chitosan; Drug Carriers; Drug Liberation; Ear; Imiquimod; Immunosuppressive Agents; Mice, Inbred C57BL; Nanoparticles; Particle Size; Psoriasis; Rats, Sprague-Dawley; Skin; Tacrolimus

2021
Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Antioxidants; Catechin; Cell Differentiation; Cells, Cultured; Chitosan; Dermatitis; Filaggrin Proteins; Humans; Imiquimod; Keratinocytes; Mice; Mice, Inbred BALB C; Nanoparticles; Psoriasis

2018
Synergistic Effects of Photo-Irradiation and Curcumin-Chitosan/Alginate Nanoparticles on Tumor Necrosis Factor-Alpha-Induced Psoriasis-Like Proliferation of Keratinocytes.
    Molecules (Basel, Switzerland), 2019, Apr-09, Volume: 24, Issue:7

    Topics: Alginates; Cell Line, Transformed; Cell Proliferation; Chitosan; Curcumin; Drug Delivery Systems; Humans; Keratinocytes; Light; Nanoparticles; Psoriasis; Tumor Necrosis Factor-alpha

2019
The role of chitosan as coating material for nanostructured lipid carriers for skin delivery of fucoxanthin.
    International journal of pharmaceutics, 2019, Aug-15, Volume: 567

    Topics: Administration, Cutaneous; Cell Line; Cell Survival; Chitosan; Drug Carriers; Fibroblasts; Humans; Lipids; Nanostructures; Psoriasis; Xanthophylls

2019